Castleark Management’s CME Group CME Stock Holding History

Castleark Management’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1M	Hold	3,400	–	–	0.03%	221
2025 Q4	$928K	Hold	3,400	–	–	0.03%	233
2025 Q3	$919K	Hold	3,400	–	–	0.03%	227
2025 Q2	$937K	Hold	3,400	–	–	0.03%	212
2025 Q1	$902K	Hold	3,400	–	–	0.03%	220
2024 Q4	$790K	Hold	3,400	–	–	0.03%	225
2024 Q3	$750K	Hold	3,400	–	–	0.03%	206
2024 Q2	$668K	Hold	3,400	–	–	0.03%	217
2024 Q1	$732K	Hold	3,400	–	–	0.03%	221
2023 Q4	$716K	Hold	3,400	–	–	0.03%	220
2023 Q3	$681K	Hold	3,400	–	–	0.03%	208
2023 Q2	$630K	Hold	3,400	–	–	0.03%	212
2023 Q1	$651K	Sell	3,400 -104,170	-97%	-$18.8M	0.03%	206
2022 Q4	$18.1M	Hold	107,570	–	–	0.94%	28
2022 Q3	$19.1M	Buy	107,570 +32,290	+43%	+$6.38M	1.06%	25
2022 Q2	$15.4M	Buy	75,280 +71,880	+2,114%	+$15.2M	0.82%	27
2022 Q1	$809K	Hold	3,400	–	–	0.03%	221
2021 Q4	$777K	Hold	3,400	–	–	0.03%	237
2021 Q3	$657K	Hold	3,400	–	–	0.03%	239
2021 Q2	$723K	Hold	3,400	–	–	0.02%	237
2021 Q1	$694K	Hold	3,400	–	–	0.03%	239
2020 Q4	$619K	Hold	3,400	–	–	0.02%	272
2020 Q3	$569K	Hold	3,400	–	–	0.02%	266
2020 Q2	$553K	Hold	3,400	–	–	0.02%	256
2020 Q1	$588K	Sell	3,400 -57,820	-94%	-$11.5M	0.03%	219
2019 Q4	$12.3M	Sell	61,220 -119,830	-66%	-$24.6M	0.49%	46
2019 Q3	$38.3M	Sell	181,050 -11,852	-6%	-$2.48M	1.56%	7
2019 Q2	$37.4M	Buy	192,902 +49,216	+34%	+$9.07M	1.44%	12
2019 Q1	$23.6M	Sell	143,686 -61,499	-30%	-$10.9M	0.89%	29
2018 Q4	$38.6M	Sell	205,185 -17,110	-8%	-$3.16M	1.64%	8
2018 Q3	$37.8M	Sell	222,295 -2,200	-1%	-$370K	1.09%	16
2018 Q2	$36.8M	Sell	224,495 -3,040	-1%	-$497K	1.13%	16
2018 Q1	$36.8M	Sell	227,535 -105,644	-32%	-$16.8M	1.17%	16
2017 Q4	$48.7M	Sell	333,179 -18,045	-5%	-$2.57M	1.46%	7
2017 Q3	$47.7M	Sell	351,224 -24,545	-7%	-$3.1M	1.5%	7
2017 Q2	$47.1M	Sell	375,769 -16,010	-4%	-$1.91M	1.54%	6
2017 Q1	$46.5M	Buy	391,779 +102,056	+35%	+$12.3M	1.46%	7
2016 Q4	$33.4M	Sell	289,723 -192,477	-40%	-$21.4M	1.07%	16
2016 Q3	$50.4M	Buy	482,200 +42,160	+10%	+$4.4M	1.52%	10
2016 Q2	$42.9M	Sell	440,040 -36,320	-8%	-$3.43M	1.37%	13
2016 Q1	$45.8M	Sell	476,360 -11,290	-2%	-$1.03M	1.43%	14
2015 Q4	$44.2M	Sell	487,650 -7,980	-2%	-$751K	1.33%	22
2015 Q3	$46M	Sell	495,630 -20,700	-4%	-$1.97M	1.48%	14
2015 Q2	$48M	Buy	516,330 +33,760	+7%	+$3.15M	1.28%	16
2015 Q1	$45.7M	Sell	482,570 -11,760	-2%	-$1.09M	1.1%	17
2014 Q4	$43.8M	Buy	494,330 +490,930	+14,439%	+$41.6M	1.13%	25
2014 Q3	$252K	Hold	3,400	–	–	0.01%	287
2014 Q2	$241K	Hold	3,400	–	–	0.01%	296
2014 Q1	$252K	Sell	3,400 -865,512	-100%	-$65.3M	0.01%	287
2013 Q4	$68.2M	Buy	868,912 +865,512	+25,456%	+$67.8M	1.98%	11
2013 Q3	$272K	Sell	3,400 -865,370	-100%	-$63.8M	0.01%	316
2013 Q2	$66M	Buy	+868,770	New	+$57M	2.19%	12

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Castleark Management's CME Position: Q1 2026 in Review

Castleark Management held its CME Group (CME) position steady in Q1 2026 at 3,400 shares worth $1M. The position accounts for 0.03% of the portfolio, ranked #221.

Castleark Management first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $68.2M in Q4 2013. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Castleark Management held 3,400 shares of CME Group worth $1M as of Q1 2026.
Castleark Management left its CME Group share count unchanged in Q1 2026.
CME Group made up 0.03% of Castleark Management's portfolio in Q1 2026, its #221 holding.
Castleark Management first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
Castleark Management's CME Group position peaked at $68.2M in Q4 2013.
1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Castleark Management's 13F filing for Q1 2026, filed 15 May 2026.